Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia
- PMID: 24565215
- PMCID: PMC3981054
- DOI: 10.1186/alzrt198
Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia
Abstract
There have been several newly proposed sets of diagnostic criteria for Alzheimer's disease/mild cognitive impairment, advanced by the National Institute of Aging/Alzheimer's Association working groups in 2011 and by the International Working Group in 2007 and 2010. These sets each aim to provide broader disease stage coverage with incorporation of disease biomarkers into the diagnostic process. They have focused particular attention on the earlier identification of disease with focus on the preclinical and predementia stages. This paper reviews these diagnostic criteria and provides 2012 consensus recommendations from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia on their applications in both clinical and research settings.
Similar articles
-
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.Brain. 2015 May;138(Pt 5):1327-38. doi: 10.1093/brain/awv029. Epub 2015 Feb 17. Brain. 2015. PMID: 25693589 Free PMC article.
-
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Rev Neurol (Paris). 2012. PMID: 22579080 Review. French.
-
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018. Alzheimers Dement. 2018. PMID: 29653606 Free PMC article. Review.
-
[Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease].Vertex. 2012 Jan-Feb;23(101):5-15. Vertex. 2012. PMID: 22880190 Spanish.
-
Predementia constructs: Mild cognitive impairment or mild neurocognitive disorder? A narrative review.Int J Geriatr Psychiatry. 2021 May;36(5):743-755. doi: 10.1002/gps.5474. Epub 2020 Dec 19. Int J Geriatr Psychiatry. 2021. PMID: 33340379 Review.
Cited by
-
Associations between Plasma Biomarkers and Cognition in Patients with Alzheimer's Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and Longitudinal Study.J Clin Med. 2019 Nov 6;8(11):1893. doi: 10.3390/jcm8111893. J Clin Med. 2019. PMID: 31698867 Free PMC article.
-
Accuracy of a Self-Administered Online Cognitive Assessment in Detecting Amnestic Mild Cognitive Impairment.J Gerontol B Psychol Sci Soc Sci. 2022 Feb 3;77(2):341-350. doi: 10.1093/geronb/gbab097. J Gerontol B Psychol Sci Soc Sci. 2022. PMID: 34333629 Free PMC article.
-
Assessment of the Knowledge and Attitude Towards Dementia Among Undergraduate University Students in Uganda.Adv Med Educ Pract. 2021 Jun 14;12:635-646. doi: 10.2147/AMEP.S301445. eCollection 2021. Adv Med Educ Pract. 2021. PMID: 34163279 Free PMC article.
-
Motoric Cognitive Risk Syndrome and the Risk of Incident Dementia: A Systematic Review and Meta-Analysis of Cohort Studies.Gerontology. 2024;70(5):479-490. doi: 10.1159/000535082. Epub 2024 Mar 8. Gerontology. 2024. PMID: 38461816 Free PMC article.
-
Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial.Front Med (Lausanne). 2022 Sep 6;9:951889. doi: 10.3389/fmed.2022.951889. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36148467 Free PMC article.
References
-
- McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement. 2011;5:263–269. doi: 10.1016/j.jalz.2011.03.005. - DOI - PMC - PubMed
-
- Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement. 2011;5:270–279. doi: 10.1016/j.jalz.2011.03.008. - DOI - PMC - PubMed
-
- Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement. 2011;5:280–292. doi: 10.1016/j.jalz.2011.03.003. - DOI - PMC - PubMed
-
- Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;5:734–746. doi: 10.1016/S1474-4422(07)70178-3. - DOI - PubMed
-
- Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010;5:1118–1127. doi: 10.1016/S1474-4422(10)70223-4. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources